Ken Griffin Zimmer Biomet Holdings, Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$106.25 - $130.01 $1.06 Million - $1.3 Million	10,000 Added 9.86%	111,400 $12.1 Million
Q1 2024 May 15, 2024	SELL	$119.98 - $132.61 $11.8 Million - $13.1 Million	-98,700 Reduced 49.33%	101,400 $13.4 Million
Q4 2023 Feb 14, 2024	BUY	$102.72 - $121.7 $13.4 Million - $15.9 Million	130,500 Added 187.5%	200,100 $24.4 Million
Q3 2023 Nov 14, 2023	SELL	$110.76 - $143.18 $2.59 Million - $3.35 Million	-23,400 Reduced 25.16%	69,600 $7.81 Million
Q2 2023 Aug 14, 2023	BUY	$126.43 - $145.6 $7.99 Million - $9.2 Million	63,200 Added 212.08%	93,000 $13.5 Million
Q1 2023 May 15, 2023	SELL	$121.91 - $130.94 $1.07 Million - $1.15 Million	-8,800 Reduced 22.8%	29,800 $3.85 Million
Q4 2022 Feb 14, 2023	SELL	$104.7 - $128.4 $16.5 Million - $20.3 Million	-157,900 Reduced 80.36%	38,600 $4.92 Million
Q3 2022 Nov 14, 2022	BUY	$101.65 - $119.27 $6.86 Million - $8.05 Million	67,500 Added 52.33%	196,500 $20.5 Million

1,094

185M

313K

475K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $21.9B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.